Guest 0
  • Dark theme: Off
  • Dark theme

    Dark theme turns the light surfaces of the page dark, creating an experience ideal for night. Try it out!

    Your Dark theme setting will apply to this browser only.

    Dark theme
  • Language: English
  • Choose your language
    English
  • Sign In
Sign In
  • Home
  • Browse
  • Upload

Search results "Changer"

Filters

Type

  • Videos
  • Streams
  • Case Quizzes
  • Podcasts
  • Presentations
  • Blogs
  • Playlists
0

Date

  • Last Hour
  • Today
  • This Week
  • This Month
  • This Year
0

Duration

  • Short (< 10 minutes)
  • Average (10-20 minutes)
  • Long (> 20 minutes)
0

Features

  • SD (360p/480p)
  • HD (720p/1080p)
  • Embedded
  • Static
  • Animated
0
  • Relevance
  • Promoted
  • Recent
  • Featured
  • Most Viewed
  • Most Liked
  • Most Commented
  • Top Favorites
  • Most Responded

Relevant Videos

  • Watch Later
    SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
    SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
    53:09

    SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"

    medcases00
    116 views 1532 days ago

Promoted Videos

Recent Videos

Featured Videos

Most Viewed Videos

Most Liked Videos

Most Commented Videos

Top Favorite Videos

Most Responded Videos

Browse KidneyTube

  • Browse Videos
  • Browse Streams
  • Browse Case Quiz
  • Browse Podcasts
  • Browse Presentations
  • Browse CME Blogs

Best of KidneyTube

  • Today's Picks
  • A-GLOMERULAR DIS
  • a-Amyloidosis
  • a-Diabetic Nephropathy
  • a-Fibrillary GN
  • a-FSGS
  • a-Hereditary Nephritis
  • a-Hematuria Symptom
  • a-IgA Nephropathy
  • a-Infection and GN
  • a-Immunotactoid GN
  • a-Membranous disease
  • a-C3 GN- MPGN
  • a-Minimal change disease
  • a-MGRS -Myeloma Kidney
  • a-Anti GBM disease
  • a-systemic disease
  • a-SLE and Kidney
  • a-RPGN
  • a-TMA - microangiopathy
  • a-Vasculitis and Kidney
  • a-Miscellaneous
  • a-Fabrys disease
  • B-FLUID & LYTES
  • b-hypercalcemia
  • b-Hyperkalemia
  • b-Hypermagnesia
  • b-Hypernatremia
  • b-Hyperphosphatemia
  • b-Hypocalcemia
  • b-Hypokalemia
  • b-Hypomagnesia
  • b-Hyponatremia
  • b-Hypophosphatemia
  • C-ACID BASE DIS
  • c-Metabolic Acidosis NAG
  • c-Metabolic Acidosis -AG
  • c-Metabolic Alkalosis
  • c-Miscellaneous
  • D-ACUTE INJURY
  • d-Infections and AKI
  • d-Malignancy and AKI
  • d-Obstructive uropathy
  • d-Contrast /pigment-AKI
  • d-pregnancy and AKI
  • d-Tubulointerstitial AKI
  • d-Vasc-disease & AKI
  • d-hepatorenal and AKI
  • d-miscellaneous AKI
  • d-cardiorenal AKI
  • E-TRANSPLANT
  • e-Allograft dysfunction
  • e-Donor-patient selection
  • e-Immunosuppression
  • e-Infection post transplant
  • e-Recurrent disease
  • e-Rejection post transplant
  • e-Post Transplant Ca
  • e-Miscellaneous
  • F-RENAL CYST DIS
  • f-Acquired cystic disease
  • f-Medullary cystic kidney
  • f-Polycystic kidney disease
  • f-Simple & complex cysts
  • f-Tuberous sclerosis/VHL
  • f-Miscellaenous
  • G-PERITONEAL DIAL
  • g-Infection and PD
  • g-Ultrafiltration
  • g-PD Complications
  • g-PD access
  • g-Adequacy in PD
  • g-Miscellaenous
  • H-RENAL PATH
  • h-Path teaching series
  • h-Path basic principles
  • h-Miscellaenous
  • I- HEMODIALYSIS
  • i-AKI & Dialysis
  • i- Anemia & Dialysis
  • i-CRRT
  • i-Bone Mineral Density
  • i-Home Hemodialysis
  • i-HD Complications
  • i-Dialysis Gen Topics
  • i-HTN & HD
  • i-Miscellaenous
  • J-CHRONIC DISEASE
  • j-Anemia and CKD
  • j-BMD and CKD
  • j-Systemic disease & CKD
  • j-HTN & CKD
  • j-Miscellaenous
  • K-HYPERTENSION
  • k--Secondary HTN
  • k-Resistant HTN
  • k-Essential HTN
  • k-Gestational HTN
  • k-Miscellaenous
  • k-Miscellaenous1
  • L-NEPHROLITHIASIS
  • l-calcium stones
  • l-uric acid stone
  • l-cystine stone
  • l-stone and pregnancy
  • l-diagnosis/evaluation
  • l-acute management
  • l-dent disease
  • M-MISCELLANEOUS
Contact Us Help About Us Copyright Terms of Use Privacy Policy Live Streaming

We use cookies for analytics and to improve your experience on our website. By continuing to use our site, you accept our use of cookies, Terms of Use and Privacy Policy.